協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/07/04 | 2,081 | 2,081 | 2,032 | 2,041 | -40 | -1.9% | 1,152,800 |
2017/07/03 | 2,080 | 2,098 | 2,072 | 2,081 | -6 | -0.3% | 1,024,600 |
2017/06/30 | 2,084 | 2,087 | 2,063 | 2,087 | -17 | -0.8% | 1,651,800 |
2017/06/29 | 2,103 | 2,109 | 2,095 | 2,104 | +3 | +0.1% | 875,300 |
2017/06/28 | 2,100 | 2,107 | 2,089 | 2,101 | -29 | -1.4% | 979,100 |
2017/06/27 | 2,102 | 2,131 | 2,094 | 2,130 | +28 | +1.3% | 1,461,500 |
2017/06/26 | 2,100 | 2,120 | 2,091 | 2,102 | +19 | +0.9% | 984,100 |
2017/06/23 | 2,087 | 2,095 | 2,078 | 2,083 | +18 | +0.9% | 835,800 |
2017/06/22 | 2,079 | 2,096 | 2,060 | 2,065 | +1 | ±0% | 911,300 |
2017/06/21 | 2,033 | 2,076 | 2,032 | 2,064 | -10 | -0.5% | 1,001,700 |
2017/06/20 | 2,071 | 2,084 | 2,066 | 2,074 | +13 | +0.6% | 1,160,200 |
2017/06/19 | 2,063 | 2,084 | 2,054 | 2,061 | +4 | +0.2% | 1,028,800 |
2017/06/16 | 2,031 | 2,063 | 1,998 | 2,057 | +37 | +1.8% | 2,279,700 |
2017/06/15 | 1,990 | 2,031 | 1,978 | 2,020 | +39 | +2% | 1,157,600 |
2017/06/14 | 1,984 | 1,999 | 1,978 | 1,981 | -4 | -0.2% | 760,700 |
2017/06/13 | 1,971 | 1,990 | 1,970 | 1,985 | +9 | +0.5% | 1,063,700 |
2017/06/12 | 1,938 | 1,980 | 1,932 | 1,976 | +31 | +1.6% | 897,700 |
2017/06/09 | 1,971 | 1,992 | 1,940 | 1,945 | -19 | -1% | 1,673,000 |
2017/06/08 | 1,966 | 1,977 | 1,960 | 1,964 | +5 | +0.3% | 861,900 |
2017/06/07 | 1,953 | 1,967 | 1,943 | 1,959 | +11 | +0.6% | 1,227,500 |
2017/06/06 | 1,939 | 1,963 | 1,931 | 1,948 | -11 | -0.6% | 1,448,700 |
2017/06/05 | 1,959 | 1,965 | 1,940 | 1,959 | -17 | -0.9% | 1,501,700 |
2017/06/02 | 1,957 | 1,985 | 1,948 | 1,976 | +21 | +1.1% | 1,764,900 |
2017/06/01 | 1,905 | 1,963 | 1,903 | 1,955 | +61 | +3.2% | 1,751,200 |
2017/05/31 | 1,900 | 1,938 | 1,886 | 1,894 | -76 | -3.9% | 3,426,600 |
2017/05/30 | 2,001 | 2,013 | 1,965 | 1,970 | -33 | -1.6% | 1,415,300 |
2017/05/29 | 2,012 | 2,015 | 1,996 | 2,003 | -1 | ±0% | 796,300 |
2017/05/26 | 2,021 | 2,034 | 2,003 | 2,004 | -22 | -1.1% | 977,600 |
2017/05/25 | 2,011 | 2,039 | 2,006 | 2,026 | +1 | ±0% | 1,346,600 |
2017/05/24 | 2,043 | 2,050 | 2,015 | 2,025 | +5 | +0.2% | 1,178,500 |
2017/05/23 | 2,029 | 2,037 | 2,016 | 2,020 | -19 | -0.9% | 1,114,400 |
2017/05/22 | 2,045 | 2,047 | 2,021 | 2,039 | +10 | +0.5% | 1,058,000 |
2017/05/19 | 2,045 | 2,048 | 2,022 | 2,029 | -22 | -1.1% | 1,664,600 |
2017/05/18 | 2,043 | 2,079 | 2,035 | 2,051 | -25 | -1.2% | 1,615,600 |
2017/05/17 | 2,070 | 2,087 | 2,063 | 2,076 | +18 | +0.9% | 1,521,600 |
2017/05/16 | 2,049 | 2,063 | 2,039 | 2,058 | +13 | +0.6% | 1,001,100 |
2017/05/15 | 2,021 | 2,056 | 2,013 | 2,045 | +2 | +0.1% | 1,329,900 |
2017/05/12 | 2,043 | 2,055 | 2,029 | 2,043 | +8 | +0.4% | 1,925,400 |
2017/05/11 | 2,038 | 2,041 | 2,017 | 2,035 | -14 | -0.7% | 1,278,000 |
2017/05/10 | 2,019 | 2,053 | 2,013 | 2,049 | +36 | +1.8% | 2,152,100 |
2017/05/09 | 1,987 | 2,023 | 1,981 | 2,013 | +22 | +1.1% | 1,880,000 |
2017/05/08 | 1,951 | 2,000 | 1,947 | 1,991 | +49 | +2.5% | 2,057,900 |
2017/05/02 | 1,923 | 1,945 | 1,918 | 1,942 | +7 | +0.4% | 1,397,500 |
2017/05/01 | 1,910 | 1,936 | 1,889 | 1,935 | +23 | +1.2% | 1,146,400 |
2017/04/28 | 1,920 | 1,947 | 1,904 | 1,912 | +11 | +0.6% | 1,657,300 |
2017/04/27 | 1,896 | 1,917 | 1,890 | 1,901 | +5 | +0.3% | 1,382,100 |
2017/04/26 | 1,896 | 1,916 | 1,877 | 1,896 | +5 | +0.3% | 1,562,700 |
2017/04/25 | 1,882 | 1,894 | 1,871 | 1,891 | +5 | +0.3% | 2,569,900 |
2017/04/24 | 1,900 | 1,912 | 1,875 | 1,886 | -4 | -0.2% | 2,625,900 |
2017/04/21 | 1,876 | 1,909 | 1,863 | 1,890 | +63 | +3.4% | 3,485,800 |
1801~
1850
件表示中 / 3581件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 257,000円 | +11.3% | -5.4% | 2.26% | 19.78倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 214,000円 | +5.7% | +3.9% | 2.68% | 10.65倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 502,900円 | +1.7% | -2.9% | 3.18% | 32.99倍 | 1.73倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 181,500円 | -3.5% | -50.2% | 4.41% | 14.70倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 274,400円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム